Log in to save to my catalogue

Neoadjuvant ceritinib treatment in ALK‐rearranged locally advanced adenosquamous carcinoma: A case r...

Neoadjuvant ceritinib treatment in ALK‐rearranged locally advanced adenosquamous carcinoma: A case r...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_7aa401f6790a45ac9c9676648dcc3437

Neoadjuvant ceritinib treatment in ALK‐rearranged locally advanced adenosquamous carcinoma: A case report

About this item

Full title

Neoadjuvant ceritinib treatment in ALK‐rearranged locally advanced adenosquamous carcinoma: A case report

Publisher

Melbourne: John Wiley & Sons Australia, Ltd

Journal title

Thoracic cancer, 2022-08, Vol.13 (15), p.2275-2278

Language

English

Formats

Publication information

Publisher

Melbourne: John Wiley & Sons Australia, Ltd

More information

Scope and Contents

Contents

Here, we first report a case of neoadjuvant ceritinib for locally advanced lung adenosquamous carcinoma. In this study, a locally advanced adenosquamous carcinoma (ASC) patient with EML4‐ALK fusion who achieved a partial response with neoadjuvant ceritinib treatment after a cycle of neoadjuvant chemotherapy did not show significant efficacy. A comp...

Alternative Titles

Full title

Neoadjuvant ceritinib treatment in ALK‐rearranged locally advanced adenosquamous carcinoma: A case report

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_7aa401f6790a45ac9c9676648dcc3437

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_7aa401f6790a45ac9c9676648dcc3437

Other Identifiers

ISSN

1759-7706

E-ISSN

1759-7714

DOI

10.1111/1759-7714.14558

How to access this item